Fresenius Medical Care Corp (FMS) 44.07 $FMS Statement

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Fresenius Medical Care Corp (FMS) 44.07 $FMS

Statement of Fresenius Medical Care North America Regarding Centers for Medicare & Medicaid Services Request for Information
BusinessWire - Fri Aug 19, 6:07PM CDT
In response to the Centers for Medicare & Medicaid Services' (CMS) recent Request for Information, Fresenius Medical Care North America issued the following statement:
FMS: 44.07 (-0.09)

Fresenius Medical (FMS) Q2 Earnings & Sales Lag Estimates
Zacks Equity Research - Zacks Investment Research - Thu Aug 04, 7:56AM CDT
Fresenius Medical Care (FMS) reported adjusted earnings of 48 cents per American Depositary Share (ADS) in the second quarter of 2016, missing the Zacks Consensus Estimate by a penny.
BABY: 39.27 (-0.44), MASI: 59.67 (+0.51), CPHD: 52.65 (+0.02), FMS: 44.07 (-0.09)

Amgen (AMGN) Tops Q2 Earnings & Revenues, Raises View
Arpita Dutt - Zacks Investment Research - Thu Jul 28, 7:02AM CDT
Amgen (AMGN) once again delivered a "beat and raise" quarter with growth products accounting for more than 50% of product sales.
BIIB: 313.92 (+4.10), INVA: 11.28 (+0.15), AMGN: 171.11 (-2.42), FMS: 44.07 (-0.09)

Fresenius Renal Therapies Announces the Introduction of Next Generation Sentinel Technology to Support Fluid Management Challenges in the End Stage Renal Disease Community
BusinessWire - Mon May 02, 8:51AM CDT
Fresenius Renal Therapies, a division of Fresenius Medical Care North America (FMCNA), the leading provider of products and services for the chronic kidney disease patient, announced today the introduction of its latest technological enhancement in the Crit-Line(R) technology product line, the CLiC(TM) device.
FMS: 44.07 (-0.09)

Amgen (AMGN) Tops Q1 Earnings & Revenues, Ups View
Arpita Dutt - Zacks Investment Research - Fri Apr 29, 8:14AM CDT
Amgen's (AMGN) growth products have started delivering, accounting for more than half of Q1 revenues.
MDVN: 81.47 (+0.05), AMGN: 171.11 (-2.42), FMS: 44.07 (-0.09), CELG: 107.30 (+0.99)

Fresenius Medical Care North America to Present Range of Clinical Findings Focused on Improving Renal Patient Care and Health Outcomes at the National Kidney Foundation 2016 Spring Clinical Meetings
BusinessWire - Mon Apr 25, 8:44AM CDT
Fresenius Medical Care North America (FMCNA), the continent's leading provider of kidney care products and services, announced today that the National Kidney Foundation (NKF) accepted a significant number of abstracts authored by FMCNA clinicians and caregivers for presentation at the 2016 Spring Clinical Meetings and publication in the journals affiliated with NKF. The general meeting is scheduled from April 28th to May 1st in Boston and is expected to attract more than 3,000 leading kidney professionals.
FMS: 44.07 (-0.09)

Amgen (AMGN) May Beat Q1 Earnings: Will the Stock Gain?
Arpita Dutt - Zacks Investment Research - Mon Apr 25, 7:30AM CDT
Cost control efforts, share buybacks and better-than-expected performance of new and mature products could help Amgen (AMGN) beat earnings expectations for Q1.
BMRN: 96.45 (+0.58), GILD: 79.10 (-1.52), AMGN: 171.11 (-2.42), FMS: 44.07 (-0.09)

Interface Biologics Announces the Extension of its Licensing Agreement with Fresenius Medical Care
Marketwired - Tue Feb 09, 6:31AM CST
Interface Biologics Inc. (IBI), a privately held commercial stage developer of transformative biomedical-polymer products, is pleased to announce that Fresenius Medical Care (FRANKFURT : FME)(NYSE: FMS), the worlds' largest integrated provider of dialysis products and services, has extended their exclusive licensing agreement for use of Endexo(TM) technology in chronic dialysis systems to cover the acute dialysis market (including CRRT).
FMS: 44.07 (-0.09)

Amgen Tops on Q4 Earnings & Revenues, Ups 2016 Outlook
Arpita Dutt - Zacks Investment Research - Fri Jan 29, 8:05AM CST
Amgen's (AMGN) fourth quarter results were better-than-expected with products like Enbrel, Kyprolis, Sensipar, Prolia, and Xgeva driving growth.
GILD: 79.10 (-1.52), AMGN: 171.11 (-2.42), FMS: 44.07 (-0.09), CELG: 107.30 (+0.99)

MedAssets' Shareholders Approve Takeover by Pamplona
Zacks Equity Research - Zacks Investment Research - Fri Jan 15, 1:50PM CST
MedAssets (MDAS) recently announced the approval of the previously considered merger agreement with Pamplona Capital Management, a specialist investment manager, by its shareholders.
EXAC: 27.52 (+0.18), FMS: 44.07 (-0.09), MDAS: 31.35 (+0.01), ARAY: 5.81 (+0.28)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Global Movement Urges Dr. Hak Ja Han's Release

Updated Category News Views 3

Under the shadows of Manhattan's skyline, something more than a regular service took shape. The New Yorker Hotel hosted an impassioned gathering of the Family Federation for World Peace and Unification. These folks weren't just saying their prayers; they were making a call—loud and resonant—for the release of Dr. Hak Ja Han. The Power of Collective Voices Gathering in...

Continue Reading
WEPSEA 2026 Propels Southeast Asia's Packaging Leap

Updated Category News Views 0

Revolution in Packaging: Southeast Asia Steps Up Get ready for a wake-up call in the world of packaging, folks; the Southeast Asian market is taking a sharp turn toward sustainability and technological advancement, as highlighted by WEPSEA 2026's recent wrap-up in Shanghai. Far from a mere exhibition, this gathering served as the crucible for change, where old-school...

Continue Reading
Bad Bunny Super Bowl Halftime Show Sweeps 7 Emmy Wins

Updated Category News Views 6

An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...

Continue Reading
Mermaid Folklore Meets Revolution in New Short Film

Updated Category News Views 2

A Sea Haunting Like No Other Ever feel like history's forgotten tales deserve a fresh spin? Well, this one's shaking it up! Hoyt Dwyer, an Atlanta filmmaker, flips the script on a lesser-known bit from the American Revolution. Yeah, we're talking about Hessian soldiers and sirens here. Just hang on to your hats because this ain't your typical historical retelling. A...

Continue Reading
MERACH Unveils W60 Plus: A Game Changer for Home Fitness

Updated Category News Views 1

MERACH's Ambitious Leap into European Markets Walking is one of life's simple pleasures, but it's not always convenient in our work-from-home driven world. That's where MERACH's UltraWalk W60 Plus comes in, dropping anchor in Europe like a brand new ship with all the bells and whistles. What makes this walking pad different, you ask? It's designed to become a natural...

Continue Reading
Hims & Hers Faces Class Action: Investors Beware

Updated Category News Views 2

Allegations and Legal Pressure There's trouble brewing in the land of health and wellness apps, with Hims & Hers Health, Inc. (NYSE:HIMS) taking center stage. Slap on your glasses, folks, because this one's a doozy. A class-action lawsuit has exploded against the company and some of its officers—allegations flying as they focus on serious accusations of misleading...

Continue Reading
Media Forum Spotlights Asia-Pacific Cooperation

Updated Category News Views 3

The Opening Scene: A Gathering with Purpose Well, here we go, diving right into the latest shindig in Shenzhen at the Asia-Pacific Media Forum. Held in China's Guangdong province, they've rounded up over 400 reps from every corner of the globe, all chewing over one key theme: "Building a Path to Shared Prosperity for the Asia-Pacific Community." You could say it's a step...

Continue Reading
Softcare Facilitates Standards Delegation Visit to Senegal

Updated Category News Views 3

Ever seen a whole nation's hygiene industry getting a deep dive from not just one, but three major standards bodies? That's what just went down in Senegal. Softcare opened its doors wide to folks from the Senegalese Association for Standardization (ASN), the International Organization for Standardization (ISO), and the Swedish Institute for Standards (SIS). This was no...

Continue Reading
DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts

Updated Category News Views 3

While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...

Continue Reading

Top 5 Most Recently Viewed Articles

Brunswick Corporation's 2025 Third Quarter Earnings Call Update

Updated Category News Views 138

Brunswick Corporation Announces Third Quarter Earnings Call Brunswick Corporation (NYSE: BC), a leader in marine recreation, has announced its plans to release financial results for the third quarter of 2025. Scheduled for October 23, 2025, this release will come before market hours and aims to provide comprehensive insights to its investors. Key Details of the Earnings...

Continue Reading
Regeneron Remains Firm on $1,300 Target Despite Challenges

Updated Category News Views 95

Regeneron’s Standing in the Biotechnology Sector Recently, BMO Capital has made news by reaffirming its Outperform rating alongside a significant price target of $1,300 for Regeneron Pharmaceuticals (NASDAQ: REGN). Despite some ongoing legal challenges, BMO remains hopeful about the biotech company's future. A primary area of attention is the unique formulation of...

Continue Reading
Berthel Fisher Expands with APP Financial Addition

Updated Category News Views 2

Shaking Up the Financial Services Scene Well, Berthel Fisher isn't sitting on its laurels in 2026. The Cedar Rapids-based juggernaut just rolled out the red carpet for APP Financial, a Fort Wayne outfit managing around $146 million in client assets. And if that ain't enough to make you perk up, they also announced Madyson Tracy's promotion to Vice President of Business...

Continue Reading
Lightera Unveils InvisiLight™ Home Fiber Kit for Seamless Use

Updated Category News Views 278

Lightera Introduces InvisiLight™ Home Fiber Kit Lightera, a frontrunner in innovative fiber optic solutions, proudly launches its InvisiLight Home Fiber Kit, designed to deliver ultra-fast, wired internet connectivity. This breakthrough product can be installed by consumers, allowing for a nearly invisible setup within the home. Unmatched Internet Performance...

Continue Reading
Investigation Launched for Silvaco Group, Inc. Investors

Updated Category News Views 158

Investigation for Silvaco Group, Inc. Investors Pomerantz LLP has initiated an investigation focusing on the concerns of investors involved with Silvaco Group, Inc. (NASDAQ: SVCO). If you are an investor in the company, now is a crucial time to consider your legal options. The Purpose of the Investigation Investors are being looked after as the firm investigates whether...

Continue Reading